Want to see SANA full AI Analyst Report?
Total Valuation
Sana Biotechnology has a market cap or net worth of $1.22B. The enterprise value is $940.93.
Market Cap$1.22B
Enterprise Value$940.93
Share Statistics
Sana Biotechnology has 299,360,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding299,360,630
Owned by Insiders13.64%
Owned by Institutions18.85%
Financial Efficiency
Sana Biotechnology’s return on equity (ROE) is -1.52 and return on invested capital (ROIC) is -54.08%.
Return on Equity (ROE)-1.52
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-54.08%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee0.00
Profits Per Employee-1.72M
Employee Count142
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sana Biotechnology is ―. Sana Biotechnology’s PEG ratio is 0.25.
PE Ratio―
PS Ratio0.00
PB Ratio6.41
Price to Fair Value6.41
Price to FCF-7.12
Price to Operating Cash Flow-8.79
PEG Ratio0.25
Income Statement
In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -244.17M in profits. Earnings per share was -0.96.
Revenue0.00
Gross Profit-12.75M
Operating Income-190.96M
Pretax Income-244.17M
Net Income-244.17M
EBITDA-231.42M
Earnings Per Share (EPS)-0.96
Cash Flow
In the last 12 months, operating cash flow was -132.24M and capital expenditures -2.82M, giving a free cash flow of -135.06M billion.
Operating Cash Flow-132.24M
Free Cash Flow-135.06M
Free Cash Flow per Share-0.45
Dividends & Yields
Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.54
52-Week Price Change38.38%
50-Day Moving Average3.55
200-Day Moving Average3.70
Relative Strength Index (RSI)56.04
Average Volume (3m)3.17M
Important Dates
Sana Biotechnology upcoming earnings date is Nov 5, 2026, After Close (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Sana Biotechnology as a current ratio of 1.89, with Debt / Equity ratio of 47.71%
Current Ratio1.89
Quick Ratio1.89
Debt to Market Cap0.00
Net Debt to EBITDA-0.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sana Biotechnology EV to EBITDA ratio is -4.48, with an EV/FCF ratio of -7.17.
EV to Sales0.00
EV to EBITDA-4.48
EV to Free Cash Flow-7.17
EV to Operating Cash Flow-7.21
Balance Sheet
Sana Biotechnology has $160.49M in cash and marketable securities with $73.74M in debt, giving a net cash position of $86.75M billion.
Cash & Marketable Securities$160.49M
Total Debt$73.74M
Net Cash$86.75M
Net Cash Per Share$0.29
Tangible Book Value Per Share-$0.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sana Biotechnology is $8.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.00
Price Target Upside95.12% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast28.46%